{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:05:30Z","timestamp":1794974730267,"version":"4.9.1"},"reference-count":146,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"unspecified","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","award":["EBPPG\/2021\/28"],"award-info":[{"award-number":["EBPPG\/2021\/28"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2022,10,21]]},"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>Gestational trophoblastic disease describes a group of rare pregnancy related disorders that span a spectrum of premalignant and malignant conditions. Hydatidiform mole (also termed molar pregnancy) is the most common form of this disease. Hydatidiform mole describes an abnormal conceptus containing two copies of the paternal genome, which is classified as partial when the maternal genome is present or complete when the maternal genome is absent. Hydatidiform mole typically presents in the first trimester with irregular vaginal bleeding and can be suspected on ultrasound but confirmation requires histopathological evaluation of the products of conception. Most molar pregnancies resolve without treatment after uterine evacuation, but occasionally the disease persists and develops into gestational trophoblastic neoplasia. Close monitoring of women after molar pregnancy, with regular measurement of human chorionic gonadotrophin concentrations, allows for early detection of malignancy. Given the rarity of the disease, clinical management and treatment is best provided in specialist centres where very high cure rates are achievable. This review looks at advances in the diagnosis and early management of gestational trophoblastic disease and highlights updates to disease classification and clinical guidelines. Use of molecular genotyping for improved diagnostic accuracy and risk stratification is reviewed and future biomarkers for the earlier detection of malignancy are considered.<\/jats:p>","DOI":"10.1136\/bmjmed-2022-000321","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T10:40:20Z","timestamp":1671187220000},"page":"e000321","source":"Crossref","is-referenced-by-count":48,"title":["Advances in the diagnosis and early management of gestational trophoblastic disease"],"prefix":"10.1136","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7231-8331","authenticated-orcid":false,"given":"Caroline M","family":"Joyce","sequence":"first","affiliation":[{"name":"Pregnancy Loss Research Group, Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland"},{"name":"INFANT Research Centre, University College Cork, Cork, Ireland"},{"name":"Department of Biochemistry and Cell Biology, University College Cork, Cork, Ireland"},{"name":"Department of Clinical Biochemistry, Cork University Hospital, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8509-088X","authenticated-orcid":false,"given":"Brendan","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Pregnancy Loss Research Group, Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland"},{"name":"Department of Pathology, Cork University Hospital, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-6972","authenticated-orcid":false,"given":"Tommie V","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cell Biology, University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Coulter","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-2887","authenticated-orcid":false,"given":"Keelin","family":"O'Donoghue","sequence":"additional","affiliation":[{"name":"Pregnancy Loss Research Group, Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland"},{"name":"INFANT Research Centre, University College Cork, Cork, Ireland"},{"name":"Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,16]]},"reference":[{"key":"2025090801201590000_1.1.e000321.1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e3282dc94e5"},{"key":"2025090801201590000_1.1.e000321.2","doi-asserted-by":"publisher","DOI":"10.3109\/01443615.2013.771159"},{"key":"2025090801201590000_1.1.e000321.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60280-2"},{"key":"2025090801201590000_1.1.e000321.4","doi-asserted-by":"crossref","first-page":"vi39","DOI":"10.1093\/annonc\/mdt345","article-title":"Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24 Suppl 6","author":"Seckl","year":"2013","journal-title":"Ann Oncol"},{"key":"2025090801201590000_1.1.e000321.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.02.011"},{"key":"2025090801201590000_1.1.e000321.6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bpobgyn.2021.01.006","article-title":"Treatment of low-risk gestational trophoblastic neoplasia","volume":"74","author":"Winter","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025090801201590000_1.1.e000321.7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/GCO.0000000000000674","article-title":"Treatment of gestational trophoblastic disease in the 2020s","volume":"33","author":"Clark","year":"2021","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2025090801201590000_1.1.e000321.8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bpobgyn.2021.01.005","article-title":"Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance\/relapsed disease","volume":"74","author":"Braga","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025090801201590000_1.1.e000321.9","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-200309000-00006"},{"key":"2025090801201590000_1.1.e000321.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67251-8"},{"key":"2025090801201590000_1.1.e000321.11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2015.11.014","article-title":"Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study","volume":"140","author":"Eysbouts","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/0284186X.2018.1438653","article-title":"Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study","volume":"57","author":"Joneborg","year":"2018","journal-title":"Acta Oncol"},{"key":"2025090801201590000_1.1.e000321.13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ygyno.2021.10.003","article-title":"Epidemiology, diagnosis, and treatment of gestational trophoblastic disease: a Society of gynecologic oncology evidenced-based review and recommendation","volume":"163","author":"Horowitz","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.14","first-page":"e1","article-title":"Management of gestational trophoblastic disease","volume":"128","author":"Tidy","year":"2021","journal-title":"BJOG"},{"key":"2025090801201590000_1.1.e000321.15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2003.01413.x"},{"key":"2025090801201590000_1.1.e000321.16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygyno.2016.07.117","article-title":"Effect of race\/ethnicity on risk of complete and partial molar pregnancy after adjustment for age","volume":"143","author":"Melamed","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13669-013-0070-7","article-title":"Clinical epidemiology of gestational trophoblastic disease","volume":"3","author":"Strohl","year":"2014","journal-title":"Curr Obstet Gynecol Rep"},{"key":"2025090801201590000_1.1.e000321.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)01245-2"},{"key":"2025090801201590000_1.1.e000321.19","first-page":"341","article-title":"The demographics of molar pregnancies in England and Wales from 2000-2009","volume":"55","author":"Savage","year":"2010","journal-title":"J Reprod Med"},{"key":"2025090801201590000_1.1.e000321.20","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-017-1256-9","article-title":"Hemoptysis as primary manifestation in three women with choriocarcinoma with pulmonary metastasis: a case series","volume":"11","author":"Zhang","year":"2017","journal-title":"J Med Case Rep"},{"key":"2025090801201590000_1.1.e000321.21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tjog.2015.05.011","article-title":"Unusual clinical presentations of choriocarcinoma: a systematic review of case reports","volume":"56","author":"Mangla","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2025090801201590000_1.1.e000321.22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/1471-0528.16202","article-title":"Demographics, natural history and treatment outcomes of non-molar gestational choriocarcinoma: a UK population study","volume":"127","author":"Savage","year":"2020","journal-title":"BJOG"},{"key":"2025090801201590000_1.1.e000321.23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/PGP.0000000000000232","article-title":"Invasive complete hydatidiform moles: analysis of a case series with genotyping","volume":"35","author":"Bynum","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"2025090801201590000_1.1.e000321.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2021.01.004"},{"key":"2025090801201590000_1.1.e000321.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02432-6"},{"key":"2025090801201590000_1.1.e000321.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2006.00697.x"},{"key":"2025090801201590000_1.1.e000321.27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/AOG.0000000000004240","article-title":"Gestational trophoblastic disease: current evaluation and management","volume":"137","author":"Soper","year":"2021","journal-title":"Obstet Gynecol"},{"key":"2025090801201590000_1.1.e000321.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60618-8"},{"key":"2025090801201590000_1.1.e000321.29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ygyno.2011.01.002","article-title":"Increase in the incidence of gestational trophoblastic disease in the Netherlands","volume":"121","author":"Lybol","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7150\/jca.28134","article-title":"Epithelioid trophoblastic tumors: treatments, outcomes, and potential therapeutic targets","volume":"10","author":"Yang","year":"2019","journal-title":"J Cancer"},{"key":"2025090801201590000_1.1.e000321.31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5858\/arpa.2018-0234-RA","article-title":"Gestational trophoblastic tumors: a timely review of diagnostic pathology","volume":"143","author":"Hui","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"2025090801201590000_1.1.e000321.32","doi-asserted-by":"crossref","first-page":"e235756","DOI":"10.1136\/bcr-2020-235756","article-title":"Placental site trophoblastic tumour: the rarest subtype of gestational trophoblastic disease","volume":"13","author":"Chaves","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2025090801201590000_1.1.e000321.33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bpobgyn.2020.10.004","article-title":"Placental site trophoblastic tumour and epithelioid trophoblastic tumour","volume":"74","author":"Hancock","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025090801201590000_1.1.e000321.34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2016.10.024","article-title":"Placental site trophoblastic tumors and epithelioid trophoblastic tumors: biology, natural history, and treatment modalities","volume":"144","author":"Horowitz","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.35","doi-asserted-by":"publisher","DOI":"10.1177\/1742271X17748514"},{"key":"2025090801201590000_1.1.e000321.36","doi-asserted-by":"publisher","DOI":"10.1002\/uog.2592"},{"key":"2025090801201590000_1.1.e000321.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.05.002"},{"key":"2025090801201590000_1.1.e000321.38","first-page":"629","article-title":"Changes of clinical features in hydatidiform mole: analysis of 113 cases","volume":"53","author":"Hou","year":"2008","journal-title":"J Reprod Med"},{"key":"2025090801201590000_1.1.e000321.39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155 Suppl 1","author":"Ngan","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"2025090801201590000_1.1.e000321.40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mpdhp.2018.12.002","article-title":"Gestational trophoblast disease: clinical presentation and treatment","volume":"25","author":"Seckl","year":"2019","journal-title":"Diagnostic Histopathology"},{"key":"2025090801201590000_1.1.e000321.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09085-2"},{"key":"2025090801201590000_1.1.e000321.42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1515\/med-2019-0098","article-title":"Partial hydatidiform mole and coexistent live fetus: a case report and review of the literature","volume":"14","author":"Zeng","year":"2019","journal-title":"Open Med"},{"key":"2025090801201590000_1.1.e000321.43","doi-asserted-by":"crossref","unstructured":"Russell JC , Niemann I , Sebire NJ . P176 update on UK outcomes in twin pregnancies with complete hydatidiform mole and normal co-twin: a retrospective national cohort study in 153 new cases. BMJ Specialist Journals 2019.","DOI":"10.1136\/ijgc-2019-ESGO.236"},{"key":"2025090801201590000_1.1.e000321.44","unstructured":"Niemann L , Fisher R , Sebire NJ . Update on UK outcomes for women with twin pregnancies comprising a complete hydatidiform mole and normal co-twin. In: XVII world Congress on gestational trophoblastic disease, 2013: 57 (Abstract)."},{"key":"2025090801201590000_1.1.e000321.45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2017.01.021","article-title":"Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: a retrospective multicenter cohort and literature review","volume":"145","author":"Lin","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.46","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/1471-0528.16283","article-title":"Obstetric outcomes of twin pregnancies presenting with a complete hydatidiform mole and coexistent normal fetus: a systematic review and meta-analysis","volume":"127","author":"Zilberman Sharon","year":"2020","journal-title":"BJOG"},{"key":"2025090801201590000_1.1.e000321.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2002.t01-1-01037.x"},{"key":"2025090801201590000_1.1.e000321.48","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2016.01.005","article-title":"The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy","volume":"140","author":"Gockley","year":"2016","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1471-0528.2003.02388.x","article-title":"Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy","volume":"110","author":"Sebire","year":"2003","journal-title":"BJOG: An Internal Journal of Obs Gyn"},{"key":"2025090801201590000_1.1.e000321.50","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev169"},{"key":"2025090801201590000_1.1.e000321.51","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5871"},{"key":"2025090801201590000_1.1.e000321.52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/gyno.1999.5562","article-title":"Repetitive hydatidiform mole with different male partners","volume":"75","author":"Tuncer","year":"1999","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61751-0"},{"key":"2025090801201590000_1.1.e000321.54","doi-asserted-by":"publisher","DOI":"10.1038\/416539a"},{"key":"2025090801201590000_1.1.e000321.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.10.007"},{"key":"2025090801201590000_1.1.e000321.56","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000130"},{"key":"2025090801201590000_1.1.e000321.57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0002-9378(88)90785-5","article-title":"Dietary factors and risk of trophoblastic disease","volume":"158","author":"Parazzini","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"2025090801201590000_1.1.e000321.58","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ygyno.2008.09.005","article-title":"Gynecologic oncology current management of gestational trophoblastic diseases","volume":"112","author":"Berkowitz","year":"2009","journal-title":"Gynecol Oncol [Internet]"},{"key":"2025090801201590000_1.1.e000321.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2003.09.011"},{"key":"2025090801201590000_1.1.e000321.60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/19336918.2015.1093275","article-title":"The hydatidiform mole","volume":"10","author":"Candelier","year":"2016","journal-title":"Cell Adh Migr"},{"key":"2025090801201590000_1.1.e000321.61","doi-asserted-by":"crossref","first-page":"334.e1","DOI":"10.1016\/j.ajog.2016.04.019","article-title":"Effect of race\/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center","volume":"215","author":"Gockley","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2025090801201590000_1.1.e000321.62","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/s41379-020-0566-4","article-title":"Heterozygous\/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease","volume":"33","author":"Zheng","year":"2020","journal-title":"Modern Pathology"},{"key":"2025090801201590000_1.1.e000321.63","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41379-019-0432-4","article-title":"Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes","volume":"33","author":"Khawajkie","year":"2020","journal-title":"Mod Pathol"},{"key":"2025090801201590000_1.1.e000321.64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.path.2022.02.002","article-title":"Gestational trophoblastic disease: contemporary diagnostic approach","volume":"15","author":"Buza","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"2025090801201590000_1.1.e000321.65","first-page":"569","article-title":"Clinicopathologic study of tetraploid hydropic villous tissues","volume":"120","author":"Fukunaga","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"2025090801201590000_1.1.e000321.66","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jmoldx.2019.09.006","article-title":"Tetraploid partial hydatidiform moles: molecular genotyping and determination of parental contributions","volume":"22","author":"Bynum","year":"2020","journal-title":"J Mol Diagn"},{"key":"2025090801201590000_1.1.e000321.67","first-page":"595","article-title":"Familial recurrent hydatidiform mole: a review","volume":"49","author":"Fisher","year":"2004","journal-title":"J Reprod Med"},{"key":"2025090801201590000_1.1.e000321.68","doi-asserted-by":"publisher","DOI":"10.1038\/ng1740"},{"key":"2025090801201590000_1.1.e000321.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2011.08.002"},{"key":"2025090801201590000_1.1.e000321.70","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s10815-021-02132-1","article-title":"The genetics of recurrent hydatidiform moles in Mexico: further evidence of a strong founder effect for one mutation in NLRP7 and its widespread","volume":"38","author":"Aguinaga","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2025090801201590000_1.1.e000321.71","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.3.594"},{"key":"2025090801201590000_1.1.e000321.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80559-0"},{"key":"2025090801201590000_1.1.e000321.73","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-052016-100237"},{"key":"2025090801201590000_1.1.e000321.74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00185"},{"key":"2025090801201590000_1.1.e000321.75","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deg060"},{"key":"2025090801201590000_1.1.e000321.76","unstructured":"WHO Classification of Tumours Editorial board ed . World Health Organisation Classification of Tumours. Female genital tumours. 5th ed. Lyon: IARC Press, 2020."},{"key":"2025090801201590000_1.1.e000321.77","unstructured":"Berkowitz RS , Horowitz DP , Elias KM . Hydatidiform mole: epidemiology, clinical manifestations and diagnosis. Waltham, MA: UpToDate, Post TW(Ed) UpToDate, 2022."},{"key":"2025090801201590000_1.1.e000321.78","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/PGP.0000000000000128","article-title":"Atypical placental site nodule (APSN) and association with malignant gestational trophoblastic disease; a clinicopathologic study of 21 cases","volume":"34","author":"Kaur","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"2025090801201590000_1.1.e000321.79","doi-asserted-by":"crossref","first-page":"300593","DOI":"10.1016\/j.hpr.2022.300593","article-title":"Non-gestational choriocarcinoma of ovary: Clinico-morphological features and diagnostic value of DNA polymorphism study","volume":"27","author":"Magnaeva","year":"2022","journal-title":"Hum Pathol Reports"},{"key":"2025090801201590000_1.1.e000321.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.06.072"},{"key":"2025090801201590000_1.1.e000321.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2004.05.008"},{"key":"2025090801201590000_1.1.e000321.82","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.143"},{"key":"2025090801201590000_1.1.e000321.83","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-016-0471-9"},{"key":"2025090801201590000_1.1.e000321.84","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800175"},{"key":"2025090801201590000_1.1.e000321.85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2020.04.011","article-title":"p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 cases","volume":"101","author":"Gaillot-Durand","year":"2020","journal-title":"Hum Pathol"},{"key":"2025090801201590000_1.1.e000321.86","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e3182630d8c"},{"key":"2025090801201590000_1.1.e000321.87","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.033571"},{"key":"2025090801201590000_1.1.e000321.88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/15513810802545350","article-title":"Immunohistochemical expression of p57 in placental vascular proliferative disorders of preterm and term placentas","volume":"28","author":"Allias","year":"2009","journal-title":"Fetal Pediatr Pathol"},{"key":"2025090801201590000_1.1.e000321.89","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.placenta.2020.12.011","article-title":"Discovery of inverted discordant p57 expression in random clusters of dysmorphic chorionic villi of third trimester placentas suggests a more common occurrence of such phenomenon than initially described","volume":"104","author":"Carreon","year":"2021","journal-title":"Placenta"},{"key":"2025090801201590000_1.1.e000321.90","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2018-0226-RA"},{"key":"2025090801201590000_1.1.e000321.91","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0047-OA"},{"key":"2025090801201590000_1.1.e000321.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2010.06.005"},{"key":"2025090801201590000_1.1.e000321.93","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml029"},{"key":"2025090801201590000_1.1.e000321.94","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bpobgyn.2021.05.001","article-title":"Human chorionic gonadotrophin assays to monitor GTD","volume":"74","author":"McMahon","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025090801201590000_1.1.e000321.95","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/clinchem\/43.12.2233","article-title":"Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites","volume":"43","author":"Cole","year":"1997","journal-title":"Clin Chem"},{"key":"2025090801201590000_1.1.e000321.96","first-page":"285","article-title":"Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors","volume":"55","author":"Harvey","year":"2010","journal-title":"J Reprod Med"},{"key":"2025090801201590000_1.1.e000321.97","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.038679"},{"key":"2025090801201590000_1.1.e000321.98","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.124578"},{"key":"2025090801201590000_1.1.e000321.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.06.073"},{"key":"2025090801201590000_1.1.e000321.100","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2011.011073"},{"key":"2025090801201590000_1.1.e000321.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2017.08.015"},{"key":"2025090801201590000_1.1.e000321.102","first-page":"720","article-title":"\u201cHook effect\u201d in complete hydatiform molar pregnancy: a falsely low level of beta-HCG","volume":"82","author":"Lavavi","year":"1993","journal-title":"Obs Gynecol"},{"key":"2025090801201590000_1.1.e000321.103","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s13669-013-0071-6","article-title":"Management of chemoresistant and quiescent gestational trophoblastic disease","volume":"3","author":"Ngu","year":"2014","journal-title":"Curr Obstet Gynecol Rep"},{"key":"2025090801201590000_1.1.e000321.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2016.11.017"},{"key":"2025090801201590000_1.1.e000321.105","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.053595"},{"key":"2025090801201590000_1.1.e000321.106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2011.11.001"},{"key":"2025090801201590000_1.1.e000321.107","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)01324-6"},{"key":"2025090801201590000_1.1.e000321.108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bpobgyn.2021.05.006","article-title":"Progress to international harmonisation of care and future developments","volume":"74","author":"Seckl","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025090801201590000_1.1.e000321.109","first-page":"CD007102","article-title":"First-Line chemotherapy in low-risk gestational trophoblastic neoplasia","volume":"2016","author":"Lawrie","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090801201590000_1.1.e000321.110","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der265"},{"key":"2025090801201590000_1.1.e000321.111","first-page":"145","article-title":"Worldwide survey of the results of treating gestational trophoblastic disease","volume":"59","author":"Kohorn","year":"2014","journal-title":"J Reprod Med"},{"key":"2025090801201590000_1.1.e000321.112","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ygyno.2020.04.704","article-title":"Gestational trophoblastic neoplasia lethality among Brazilian women: a retrospective national cohort study","volume":"158","author":"Freitas","year":"2020","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.113","unstructured":"NCCP . Diagnosis, staging and treatment of patients with gestational trophoblastic disease: National Clinical Guideline No. 13. Dep Heal Irel (An Roinn Slainte) [Internet], 2022. Available: https:\/\/health.gov.ie\/wp-content\/uploads\/2015\/12\/GTD-Guideline-Full_FINAL-APPROVED-FOR-WEB.pdf"},{"key":"2025090801201590000_1.1.e000321.114","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ygyno.2017.12.008","article-title":"What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients","volume":"148","author":"Coyle","year":"2018","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000003566","article-title":"Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization following molar pregnancy: a systematic review and meta-analysis","volume":"135","author":"Albright","year":"2020","journal-title":"Obstet Gynecol"},{"key":"2025090801201590000_1.1.e000321.116","doi-asserted-by":"crossref","first-page":"513.e1","DOI":"10.1016\/j.ajog.2021.05.031","article-title":"Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis","volume":"225","author":"Albright","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2025090801201590000_1.1.e000321.117","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2018.12.029","article-title":"Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?","volume":"234","author":"Earp","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025090801201590000_1.1.e000321.118","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5306\/wjco.v10.i2.28","article-title":"Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide","volume":"10","author":"Braga","year":"2019","journal-title":"World J Clin Oncol"},{"key":"2025090801201590000_1.1.e000321.119","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603608"},{"key":"2025090801201590000_1.1.e000321.120","unstructured":"Faculty of Sexual and Reproductive Healthcare . Contraception after pregnancy. FSRH Guidel Exec Summ, 2017: 1\u201318."},{"key":"2025090801201590000_1.1.e000321.121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.09.031"},{"key":"2025090801201590000_1.1.e000321.122","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2017.09.007","article-title":"Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?","volume":"147","author":"Dantas","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.123","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600041"},{"key":"2025090801201590000_1.1.e000321.124","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-021-00279-5"},{"key":"2025090801201590000_1.1.e000321.125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ebiom.2015.12.022","article-title":"Circulating cell free DNA in the diagnosis of trophoblastic tumors","volume":"4","author":"Openshaw","year":"2016","journal-title":"EBioMedicine"},{"key":"2025090801201590000_1.1.e000321.126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mgg3.1565","article-title":"Hydatidiform mole diagnostics using circulating gestational trophoblasts isolated from maternal blood","volume":"9","author":"Sunde","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"2025090801201590000_1.1.e000321.127","doi-asserted-by":"publisher","DOI":"10.1530\/REP-16-0060"},{"key":"2025090801201590000_1.1.e000321.128","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.03.025"},{"key":"2025090801201590000_1.1.e000321.129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2012.07.116","article-title":"Current advances in the management of gestational trophoblastic disease","volume":"128","author":"Berkowitz","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.130","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00024"},{"key":"2025090801201590000_1.1.e000321.131","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2020.100622","article-title":"Uterine artery Pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: a cohort study","volume":"45","author":"Harvey","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"2025090801201590000_1.1.e000321.132","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ygyno.2021.09.016","article-title":"Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement","volume":"163","author":"Hoeijmakers","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2025090801201590000_1.1.e000321.133","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet"},{"key":"2025090801201590000_1.1.e000321.134","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1200\/JCO.20.00803","article-title":"Avelumab in patients with gestational trophoblastic tumors with resistance to single-agent chemotherapy: cohort a of the TROPHIMMUN phase II trial","volume":"38","author":"You","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025090801201590000_1.1.e000321.135","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S1470-2045(21)00460-5","article-title":"Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (cap 01): a single-arm, open-label, phase 2 trial","volume":"22","author":"Cheng","year":"2021","journal-title":"Lancet Oncol"},{"key":"2025090801201590000_1.1.e000321.136","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(21)00262-X","article-title":"Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study","volume":"22","author":"Braga","year":"2021","journal-title":"Lancet Oncol"},{"key":"2025090801201590000_1.1.e000321.137","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/s41388-022-02251-8","article-title":"Atr and CDK4\/6 inhibition target the growth of methotrexate-resistant choriocarcinoma","volume":"41","author":"Georgiou","year":"2022","journal-title":"Oncogene"},{"key":"2025090801201590000_1.1.e000321.138","first-page":"589","article-title":"Predictors of quality of life among long-term survivors of gestational trophoblastic disease","volume":"49","author":"Wenzel","year":"2004","journal-title":"J Reprod Med"},{"key":"2025090801201590000_1.1.e000321.139","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/S1470-2045(17)30686-1","article-title":"Systematic review of health-related quality of life and patient-reported outcome measures in gestational trophoblastic disease: a parallel synthesis approach","volume":"19","author":"Ireson","year":"2018","journal-title":"Lancet Oncol"},{"key":"2025090801201590000_1.1.e000321.140","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/1471-0528.16849","article-title":"The psychological impact of gestational trophoblastic disease: a prospective observational multicentre cohort study","volume":"129","author":"Blok","year":"2022","journal-title":"BJOG"},{"key":"2025090801201590000_1.1.e000321.141","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/1471-0528.16986","article-title":"Re: the psychological impact of gestational trophoblastic disease: a prospective observational multicentre cohort study","volume":"129","author":"Sarkar","year":"2022","journal-title":"BJOG"},{"key":"2025090801201590000_1.1.e000321.142","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/1471-0528.17001","article-title":"Authors\u2019 response re: The psychological impact of gestational trophoblastic disease: a prospective observational multicentre cohort study","volume":"129","author":"Blok","year":"2022","journal-title":"BJOG"},{"key":"2025090801201590000_1.1.e000321.143","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2022.03.039","article-title":"Experience of women on the Irish national gestational trophoblastic disease registry","volume":"272","author":"Joyce","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025090801201590000_1.1.e000321.144","first-page":"239","article-title":"Assessment of quality of life and psychologic aspects in patients with gestational trophoblastic disease","volume":"54","author":"Ferreira","year":"2009","journal-title":"J Reprod Med"},{"key":"2025090801201590000_1.1.e000321.145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bpobgyn.2020.10.007","article-title":"Psychological aspects and fertility issues of GTD","volume":"74","author":"Di Mattei","year":"2021","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2025090801201590000_1.1.e000321.146","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2008.12.015"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2022-000321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:20:33Z","timestamp":1757319633000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2022-000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":146,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,16]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/bmjmed-2022-000321"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2022-000321","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]}}}